drug

daunorubicin

1 story · latest Aug 31, 2026

Status: FDA approved Jan 1998 · NDA050731
Brand: Cerubidine
Trials: 1 registered trial in coverage

Relationships

Developed by Hikma Pharmaceuticals

Also known as

daunorubicin hydrochloride

Timeline

Roswell Park's Phase II CPX-351 trial in younger secondary AML patients marked completed

Aug 31Trial updateJazz Pharmaceuticals

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.